{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:24:21Z","timestamp":1786933461961,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science and Technology project of Henan Province","award":["LHGJ20230460"],"award-info":[{"award-number":["LHGJ20230460"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02211-6","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:04:22Z","timestamp":1781089462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identifying PLAU as a shared pathogenic gene in type 2 diabetes and bladder urothelial carcinoma through integrated transcriptomic analysis and machine learning for diagnostic and therapeutic value"],"prefix":"10.1007","volume":"26","author":[{"given":"Shiyong","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sichang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"2211_CR1","doi-asserted-by":"publisher","first-page":"654718","DOI":"10.3389\/fmolb.2021.654718","volume":"8","author":"J Yang","year":"2021","unstructured":"Yang J, Xia A, Zhang H, et al. Up-Regulating ERIC by CRISPR-dCas9-VPR Inhibits Cell Proliferation and Invasion and Promotes Apoptosis in Human Bladder Cancer. Front Mol Biosci. 2021;8:654718.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"2211_CR2","first-page":"12","volume":"12","author":"DC Feng","year":"2025","unstructured":"Feng DC, Li DX, Wu RC, et al. Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046. Mil Med Res. 2025;12(1):12.","journal-title":"Mil Med Res"},{"issue":"20","key":"2211_CR3","doi-asserted-by":"publisher","first-page":"11150","DOI":"10.3390\/ijms222011150","volume":"22","author":"E Gill","year":"2021","unstructured":"Gill E, Sandhu G, Ward DG, Perks CM, Bryan RT. The Sirenic Links between Diabetes, Obesity, and Bladder Cancer. Int J Mol Sci. 2021;22(20):11150.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2211_CR4","doi-asserted-by":"publisher","first-page":"e56662","DOI":"10.1371\/journal.pone.0056662","volume":"8","author":"Z Zhu","year":"2013","unstructured":"Zhu Z, Zhang X, Shen Z, et al. Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies. PLoS ONE. 2013;8(2):e56662.","journal-title":"PLoS ONE"},{"issue":"1","key":"2211_CR5","first-page":"e21200003","volume":"11","author":"S Wu","year":"2024","unstructured":"Wu S, Xiong S, Li J, et al. A narrative review of advances in the management of urothelial cancer: Diagnostics and treatments. Bladder (San Franc). 2024;11(1):e21200003.","journal-title":"Bladder (San Franc)"},{"issue":"9","key":"2211_CR6","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1634\/theoncologist.2015-0111","volume":"20","author":"HY Kuo","year":"2015","unstructured":"Kuo HY, Lin ZZ, Kuo R, et al. The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia. Oncologist. 2015;20(9):1051\u20137.","journal-title":"Oncologist"},{"key":"2211_CR7","doi-asserted-by":"crossref","unstructured":"Sudo H, Kubo A. The Aneugenicity of Ketone Bodies in Colon Epithelial Cells Is Mediated by Microtubule Hyperacetylation and Is Blocked by Resveratrol. Int J Mol Sci. 2021;22(17):9397.","DOI":"10.3390\/ijms22179397"},{"issue":"8","key":"2211_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaoncol.2018.1684","volume":"4","author":"Y Hwangbo","year":"2018","unstructured":"Hwangbo Y, Kang D, Kang M, et al. Incidence of Diabetes After Cancer Development: A Korean National Cohort Study. JAMA Oncol. 2018;4(8):1099\u2013105.","journal-title":"JAMA Oncol"},{"issue":"11\u201312","key":"2211_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s10495-022-01751-y","volume":"27","author":"Q You","year":"2022","unstructured":"You Q, Wang J, Yu Y, et al. The histone deacetylase SIRT6 promotes glycolysis through the HIF-1\u03b1\/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer. Apoptosis. 2022;27(11\u201312):883\u201398.","journal-title":"Apoptosis"},{"issue":"8","key":"2211_CR10","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1158\/0008-5472.CAN-13-1803","volume":"74","author":"Y Yang","year":"2014","unstructured":"Yang Y. Yee D. IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC-. Cancer Res. 2014;74(8):2295\u2013305.","journal-title":"Cancer Res"},{"issue":"6","key":"2211_CR11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/ijc.30824","volume":"141","author":"I Drake","year":"2017","unstructured":"Drake I, Gullberg B, Sonestedt E, et al. Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting. Int J Cancer. 2017;141(6):1170\u201380.","journal-title":"Int J Cancer"},{"key":"2211_CR12","doi-asserted-by":"crossref","unstructured":"Zhang Q, Cheng L, Wang J et al. Antibiotic-Induced Gut Microbiota Dysbiosis Damages the Intestinal Barrier, Increasing Food Allergy in Adult Mice. Nutrients. 2021;13(10):3315.","DOI":"10.3390\/nu13103315"},{"issue":"6","key":"2211_CR13","doi-asserted-by":"publisher","first-page":"e2102303","DOI":"10.1002\/advs.202102303","volume":"9","author":"Q Hao","year":"2022","unstructured":"Hao Q, Huang Z, Li Q, et al. A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast Cancer. Adv Sci (Weinh). 2022;9(6):e2102303.","journal-title":"Adv Sci (Weinh)"},{"key":"2211_CR14","doi-asserted-by":"publisher","first-page":"108633","DOI":"10.1016\/j.diabres.2020.108633","volume":"172","author":"A Leiter","year":"2021","unstructured":"Leiter A, Carroll E, Brooks D, et al. Characterization of hyperglycemia in patients receiving immune checkpoint inhibitors: Beyond autoimmune insulin-dependent diabetes. Diabetes Res Clin Pract. 2021;172:108633.","journal-title":"Diabetes Res Clin Pract"},{"key":"2211_CR15","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.2147\/IJN.S174068","volume":"13","author":"T Yildiz","year":"2018","unstructured":"Yildiz T, Gu R, Zauscher S, et al. Doxorubicin-loaded protease-activated near-infrared fluorescent polymeric nanoparticles for imaging and therapy of cancer. Int J Nanomed. 2018;13:6961\u201386.","journal-title":"Int J Nanomed"},{"issue":"2","key":"2211_CR16","doi-asserted-by":"publisher","first-page":"166965","DOI":"10.1016\/j.bbadis.2023.166965","volume":"1870","author":"K Shi","year":"2024","unstructured":"Shi K, Zhou J, Li M, et al. Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA. Biochim Biophys Acta Mol Basis Dis. 2024;1870(2):166965.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"2211_CR17","doi-asserted-by":"publisher","first-page":"9753","DOI":"10.1080\/21655979.2021.1995101","volume":"12","author":"J Sun","year":"2021","unstructured":"Sun J, Zhou F, Xue J, Ji C, Qu Y, Pan Y. Long non-coding RNA TRPM2-AS regulates microRNA miR-138-5p and PLAU (Plasminogen Activator, Urokinase) to promote the progression of gastric adenocarcinoma. Bioengineered. 2021;12(2):9753\u201365.","journal-title":"Bioengineered"},{"key":"2211_CR18","doi-asserted-by":"publisher","first-page":"173225","DOI":"10.1016\/j.ejphar.2020.173225","volume":"880","author":"X Zhao","year":"2020","unstructured":"Zhao X, Liu Z, Ren Z, et al. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F. Eur J Pharmacol. 2020;880:173225.","journal-title":"Eur J Pharmacol"},{"key":"2211_CR19","doi-asserted-by":"publisher","first-page":"706936","DOI":"10.3389\/fimmu.2021.706936","volume":"12","author":"W Yu","year":"2021","unstructured":"Yu W, Ma Y, Hou W, et al. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma. Front Immunol. 2021;12:706936.","journal-title":"Front Immunol"},{"issue":"1","key":"2211_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41420-021-00410-6","volume":"7","author":"L Fang","year":"2021","unstructured":"Fang L, Che Y, Zhang C, et al. PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR\/Akt\/NF-\u03baB\/IL8 pathway. Cell Death Discov. 2021;7(1):32.","journal-title":"Cell Death Discov"},{"issue":"2","key":"2211_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.gendis.2023.04.010","volume":"11","author":"P Ning","year":"2023","unstructured":"Ning P, Du F, Gong X, et al. PLAU plays a functional role in driving lung squamous cell carcinoma metastasis. Genes Dis. 2023;11(2):554\u20137.","journal-title":"Genes Dis"},{"issue":"2","key":"2211_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3892\/or.2022.8462","volume":"49","author":"Y Gao","year":"2023","unstructured":"Gao Y, Ma X, Lu H, Xu P, Xu C. PLAU is associated with cell migration and invasion and is regulated by transcription factor YY1 in cervical cancer. Oncol Rep. 2023;49(2):25.","journal-title":"Oncol Rep"},{"key":"2211_CR23","doi-asserted-by":"publisher","first-page":"670384","DOI":"10.3389\/fgene.2021.670384","volume":"12","author":"F Zhang","year":"2021","unstructured":"Zhang F, Wang X, Bai Y, et al. Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer. Front Genet. 2021;12:670384.","journal-title":"Front Genet"},{"key":"2211_CR24","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3389\/fphar.2018.00866","volume":"9","author":"L Bergandi","year":"2018","unstructured":"Bergandi L, Mungo E, Morone R, et al. Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax\/Bcl-2 and Bax\/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells. Front Pharmacol. 2018;9:866.","journal-title":"Front Pharmacol"},{"key":"2211_CR25","doi-asserted-by":"publisher","first-page":"101542","DOI":"10.1016\/j.redox.2020.101542","volume":"34","author":"A Chatterjee","year":"2020","unstructured":"Chatterjee A, Kosmacek EA, Shrishrimal S, et al. MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses. Redox Biol. 2020;34:101542.","journal-title":"Redox Biol"},{"issue":"1","key":"2211_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s11556-022-00284-2","volume":"19","author":"I Pitrou","year":"2022","unstructured":"Pitrou I, Vasiliadis HM,Hudon C. Body mass index and cognitive decline among community-living older adults: the modifying effect of physical activity. Eur Rev Aging Phys Act. 2022;19(1):3.","journal-title":"Eur Rev Aging Phys Act"},{"issue":"1","key":"2211_CR27","doi-asserted-by":"publisher","first-page":"bnz014","DOI":"10.1210\/endrev\/bnz014","volume":"41","author":"IC Lega","year":"2020","unstructured":"Lega IC, Lipscombe LL, Review. Diabetes, Obesity, and Cancer-Pathophysiology and Clinical Implications. Endocr Rev. 2020;41(1):bnz014.","journal-title":"Endocr Rev"},{"key":"2211_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.tem.2010.06.007","volume":"21","author":"EJ Gallagher","year":"2010","unstructured":"Gallagher EJ, LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab. 2010;21:610\u20138.","journal-title":"Trends Endocrinol Metab"},{"key":"2211_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1158\/0008-5472.CAN-09-2141","volume":"70","author":"R Novosyadlyy","year":"2010","unstructured":"Novosyadlyy R, Lann DE, Vijayakumar A, Rowzee A, Lazzarino DA, Fierz Y, et al. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res. 2010;70:741\u201351.","journal-title":"Cancer Res"},{"key":"2211_CR30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.1241908","volume":"342","author":"ER Nelson","year":"2013","unstructured":"Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science. 2013;342:1094\u20138.","journal-title":"Science"},{"key":"2211_CR31","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/onc.2011.495","volume":"31","author":"EJ Gallagher","year":"2012","unstructured":"Gallagher EJ, Fierz Y, Vijayakumar A, Haddad N, Yakar S, Le-Roith D. Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia. Oncogene. 2012;31:3213\u201322.","journal-title":"Oncogene"},{"key":"2211_CR32","doi-asserted-by":"publisher","first-page":"699732","DOI":"10.3389\/fendo.2021.699732","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu Y, Tao J. Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021;12:699732.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2211_CR33","doi-asserted-by":"publisher","first-page":"e58079","DOI":"10.1371\/journal.pone.0058079","volume":"8","author":"X Xu","year":"2013","unstructured":"Xu X, Wu J, Mao Y, et al. Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies. PLoS ONE. 2013;8(3):e58079.","journal-title":"PLoS ONE"},{"issue":"5","key":"2211_CR34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.cmet.2022.03.011","volume":"34","author":"P Dornbos","year":"2022","unstructured":"Dornbos P, Singh P, Jang DK, et al. Evaluating human genetic support for hypothesized metabolic disease genes. Cell Metab. 2022;34(5):661\u20136.","journal-title":"Cell Metab"},{"key":"2211_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2147\/DMSO.S235011","volume":"13","author":"L Jian","year":"2020","unstructured":"Jian L, Yang G. Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer. Diabetes Metab Syndr Obes. 2020;13:463\u201376.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"2211_CR36","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1681\/ASN.V1191656","volume":"11","author":"N Tanji","year":"2000","unstructured":"Tanji N, Markowitz GS, Fu C, et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol. 2000;11(9):1656\u201366.","journal-title":"J Am Soc Nephrol"},{"key":"2211_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2018.06.001","volume":"833","author":"D Sanajou","year":"2018","unstructured":"Sanajou D, Ghorbani Haghjo A, Argani H, Aslani S. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions. Eur J Pharmacol. 2018;833:158\u201364.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"2211_CR38","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s00125-006-0468-0","volume":"49","author":"SC Larsson","year":"2006","unstructured":"Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006;49(12):2819\u201323.","journal-title":"Diabetologia"},{"issue":"8","key":"2211_CR39","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00125-011-2171-z","volume":"54","author":"CH Tseng","year":"2011","unstructured":"Tseng CH. Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan. Diabetologia. 2011;54(8):2009\u201315.","journal-title":"Diabetologia"},{"issue":"46","key":"2211_CR40","doi-asserted-by":"publisher","first-page":"e8588","DOI":"10.1097\/MD.0000000000008588","volume":"96","author":"Y Xu","year":"2017","unstructured":"Xu Y, Huo R, Chen X, Yu X. Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies. Med (Baltim). 2017;96(46):e8588.","journal-title":"Med (Baltim)"},{"key":"2211_CR41","first-page":"1156","volume":"9","author":"J Wang","year":"2026","unstructured":"Wang J, Zhang Q, Zhou C, Lyu Z, Feng D. Paraptosis Turning Cellular Stress into Therapeutic Weapon for Urological Diseases. Res (Wash D C). 2026;9:1156.","journal-title":"Res (Wash D C)"},{"issue":"6","key":"2211_CR42","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.21147\/j.issn.1000-9604.2025.06.13","volume":"37","author":"F Zhang","year":"2025","unstructured":"Zhang F, Yang Y, Zhang R, et al. Curcumol overcomes cisplatin resistance and rewires glycolysis-H3K9la-ORC6 axis to trigger ferroptosis in bladder cancer. Chin J Cancer Res. 2025;37(6):1034\u201357.","journal-title":"Chin J Cancer Res"},{"issue":"6","key":"2211_CR43","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3390\/nu12061592","volume":"12","author":"E M\u00e1rquez Campos","year":"2020","unstructured":"M\u00e1rquez Campos E, Jakobs L, Simon MC. Antidiabetic Effects of Flavan-3-ols and Their Microbial Metabolites. Nutrients. 2020;12(6):1592.","journal-title":"Nutrients"},{"issue":"17","key":"2211_CR44","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.phytochem.2006.06.020","volume":"67","author":"DG Nagle","year":"2006","unstructured":"Nagle DG, Ferreira D, Zhou YD. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry. 2006;67(17):1849\u201355.","journal-title":"Phytochemistry"},{"issue":"14","key":"2211_CR45","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.3390\/ijms21145171","volume":"21","author":"M Menegazzi","year":"2020","unstructured":"Menegazzi M, Campagnari R, Bertoldi M, Crupi R, Di Paola R, Cuzzocrea S. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19? Int J Mol Sci. 2020;21(14):5171.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2211_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12986-022-00648-6","volume":"19","author":"H Im","year":"2022","unstructured":"Im H, Lee J, Kim K, Son Y, Lee YH. Anti-obesity effects of heat-transformed green tea extract through the activation of adipose tissue thermogenesis. Nutr Metab (Lond). 2022;19(1):14.","journal-title":"Nutr Metab (Lond)"},{"key":"2211_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/DMSO.S281186","volume":"14","author":"J Jakab","year":"2021","unstructured":"Jakab J, Mi\u0161ki\u0107 B, Mik\u0161i\u0107 \u0160, et al. Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products. Diabetes Metab Syndr Obes. 2021;14:67\u201383.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"21","key":"2211_CR48","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/nu16213587","volume":"16","author":"KSN Hridayanka","year":"2024","unstructured":"Hridayanka KSN, Duttaroy AK, Basak S. Bioactive Compounds and Their Chondroprotective Effects for Osteoarthritis Amelioration: A Focus on Nanotherapeutic Strategies, Epigenetic Modifications, and Gut Microbiota. Nutrients. 2024;16(21):3587.","journal-title":"Nutrients"},{"issue":"3","key":"2211_CR49","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1002\/wsbm.70001","volume":"17","author":"N Rajinikanth","year":"2025","unstructured":"Rajinikanth N, Chauhan R, Prabakaran S. Harnessing Noncanonical Proteins for Next-Generation Drug Discovery and Diagnosis. WIREs Mech Dis. 2025;17(3):e70001.","journal-title":"WIREs Mech Dis"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02211-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02211-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02211-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T01:27:47Z","timestamp":1786930067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02211-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2211"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02211-6","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human subjects in this study were in accordance with the ethical standards of the 1964 Helsinki Declaration and its subsequent amendments, and were approved by the Ethics Committee of The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology. All participants signed the informed consent form.","order":2,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"298"}}